发明申请
US20100240717A1 NOVEL THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS
有权
新型的THIOPHENE衍生物作为S1P1 / EDG1受体激动剂
- 专利标题: NOVEL THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS
- 专利标题(中): 新型的THIOPHENE衍生物作为S1P1 / EDG1受体激动剂
-
申请号: US12160520申请日: 2007-01-10
-
公开(公告)号: US20100240717A1公开(公告)日: 2010-09-23
- 发明人: Martin Boli , David Lehmann , Boris Mathys , Claus Mueller , Oliver Nayler , Beat Steiner , Jörg Velker
- 申请人: Martin Boli , David Lehmann , Boris Mathys , Claus Mueller , Oliver Nayler , Beat Steiner , Jörg Velker
- 申请人地址: CH Allschwil
- 专利权人: ACTELION PHARMACEUTICALS LTD.
- 当前专利权人: ACTELION PHARMACEUTICALS LTD.
- 当前专利权人地址: CH Allschwil
- 优先权: CH2006/050103 20060111
- 国际申请: PCT/IB07/50070 WO 20070110
- 主分类号: A61K31/381
- IPC分类号: A61K31/381 ; C07D333/22 ; C07D413/04 ; C07D333/24 ; A61K31/4245 ; A61P37/00 ; A61P29/00 ; A61P17/00 ; A61P11/06 ; A61P3/10
摘要:
The invention relates to thiophene derivatives of formula (I)/their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents wherein: A represents *—CO—CH═CH—, *—CO—CH2CH2—, *—CO—CH2—NH—, wherein the sterisks indicate the bond that is linked to the thiophene group of Formula (I), and R1-R3 are as defined in the claims.
公开/授权文献
- US08003800B2 Thiophene derivatives as S1P1/EDG1 receptor agonists 公开/授权日:2011-08-23
信息查询